| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 03/15/2006 | CN1746190A Modified peptides as therapeutic agents |
| 03/15/2006 | CN1746189A Modified peptides as therapeutic agents |
| 03/15/2006 | CN1746188A Analog of GLP-1 |
| 03/15/2006 | CN1746187A Atrial fibrillation peccant gene and use thereof |
| 03/15/2006 | CN1746186A Atrial fibrillation peccant gene and use thereof |
| 03/15/2006 | CN1746185A Analog of Exendin 4 |
| 03/15/2006 | CN1746184A Trichosanthin mutant and coding gene thereof |
| 03/15/2006 | CN1746183A Coronavirus (SARS-CoV)B-cell antigen determinate cluster with extensive cross immune activity |
| 03/15/2006 | CN1245513C Bacillus thuringiensis CryET29 compositions toxic to coleopteran insects and ctenocephalides spp |
| 03/15/2006 | CN1245512C Vaccines containing recombinant pilin against i cneisseria gonorrhoeae (or i cneisseria meningitidis) |
| 03/15/2006 | CN1245511C Anhydrant gene BcDh1 and the application of its promoter in raising drought-enduring plant |
| 03/15/2006 | CN1245509C Production of hirudin mutant HV2-Lys47 and special expression carrier and strain |
| 03/15/2006 | CN1245508C Human atrial natriuretic peptide gene, its strong mutant and its application in treating relative diseases |
| 03/15/2006 | CN1245420C Intercalated peptide from human chorionic gonadotropin of biologic synthesis and its preparing method |
| 03/15/2006 | CN1245419C Polynucleotides and polypeptides BASB033 from neisseria meningitidis and their uses |
| 03/15/2006 | CN1245418C Novel cynthetic antibiotic peptide and its preparing method and use |
| 03/15/2006 | CN1245217C Novel vaccine preparation consisting of DNA vaccine and inactivated rabies virus vaccine |
| 03/15/2006 | CN1245215C Recombination high efficiency composite interferon used as hepatitis B surface antigen and e antigen inhibitor |
| 03/14/2006 | USRE39015 Recombinant polynucleotide or expression vector encoding an antigenic protein, cytokines, antibodies, fusion proteins; open reading frame; isolate host cell; control immune system |
| 03/14/2006 | US7012547 Electronic vehicle toll collection system and method |
| 03/14/2006 | US7012177 Inbred corn line PH714 |
| 03/14/2006 | US7012134 Dendritic enriched secreted lymphocyte activation molecule |
| 03/14/2006 | US7012133 Antibodies to C-C chemokine Receptor 3 Protein |
| 03/14/2006 | US7012132 Modified factor VIII |
| 03/14/2006 | US7012131 Pro1410 polypeptides |
| 03/14/2006 | US7012130 differential saline precipitation, hydrophobic interaction chromatography, concentration and diafiltration, anionic exchange chromatography, cationic exchange chromatography, concentration and diafiltration, and molecular exclusion chromatography |
| 03/14/2006 | US7012128 Interaction between cyclin D1 and steroid receptor co-activators and uses thereof in assays |
| 03/14/2006 | US7012127 site-directed mutagenesis; for prevention and treatment of sepsis and other endotoxin-related disorders |
| 03/14/2006 | US7012063 Reducing axon degeneration with proteasome inhibitors |
| 03/14/2006 | US7012060 administering to patient a TNF receptor, the improvement wherein TNF receptor is administered with dehydroepiandrosterone simultaneously, separately or sequentially, so as to achieve an effective blood level of the combination |
| 03/14/2006 | US7011973 recombinant DNA molecules comprising regulatory sequences of an intron of the Vascular Endothelial Growth Factor receptor-2 gene or of a gene homologous to the Flk-1 gene, being capable of conferring expression of a heterologous DNA sequence |
| 03/14/2006 | US7011972 Fusion polypeptide comprising two ligand binding domains |
| 03/14/2006 | US7011969 Preparing surface tension protein via genetcally engineered bacillus culture for use in detergents, emulsifiers, wetting agents, dispersants, solubilizing agents, antistatic agents, cosmetics, foods and medical preparations |
| 03/14/2006 | US7011968 Fragments of virus protein 2 or 3 of the polyoma virus, used for transporting active ingredients |
| 03/14/2006 | US7011967 Seripancrin |
| 03/14/2006 | US7011951 Apoptosis-associated gene |
| 03/14/2006 | US7011851 Drug delivery; incontinence therapy |
| 03/14/2006 | US7011836 Neisseria having mutations in genes which causes the bacterium to lack endotoxic lipopolysaccharides, used for inoculation; genetic engineering; knockouts |
| 03/14/2006 | US7011833 Enhancing immune responses with B7-1 or B7-2 in the absence of a crosslinking agent |
| 03/14/2006 | US7011826 Control of acidosis |
| 03/14/2006 | US7011825 Erythropoietin solution preparation |
| 03/14/2006 | US7011816 Complex of gallium-68 with a macrocyclic chelating agent linked via peptidyl spacer to one or more recognition units recognized by a multispecific targeting antibody |
| 03/14/2006 | CA2324348C Methods and compositions for peptide synthesis |
| 03/14/2006 | CA2257294C Process for the purification of human interleukin-1 receptor antagonist from recombinant e. coli |
| 03/14/2006 | CA2192942C Synthetic leader peptide sequences |
| 03/14/2006 | CA2146658C Dna compounds comprising sequences encoding mannuronan c-5-epimerase |
| 03/14/2006 | CA2141300C Assessment of vitamin d receptors allelic variation |
| 03/14/2006 | CA1341501C Vectors for the expression and segregation of hirudine by transformed yeasts |
| 03/09/2006 | WO2006026780A1 Degradable clostridial toxins |
| 03/09/2006 | WO2006026689A2 Multivalent meningococcal derivatized polysaccharide-protein conjugates and vaccine |
| 03/09/2006 | WO2006026508A2 Modified hiv-1 envelope proteins |
| 03/09/2006 | WO2006026358A2 Sperm specific raft associated proteins |
| 03/09/2006 | WO2006026184A2 Blood brain barrier permeation peptides |
| 03/09/2006 | WO2006026002A2 T cell receptors with enhanced sensitivity recognition of antigen |
| 03/09/2006 | WO2006025536A1 Anti-sars virus agent |
| 03/09/2006 | WO2006025425A1 Protein participating in inhibition of plasmodium growth |
| 03/09/2006 | WO2006024954A2 Domains and epitopes of meningococcal protein nmb1870 |
| 03/09/2006 | WO2006024796A1 Novel phosphorylated phosphatase cdc25b sequences, antibodies directed against said sequences and uses thereof |
| 03/09/2006 | WO2006024752A1 Modified hiv-1 peptides and use thereof in the detection of anti-hiv antibodies |
| 03/09/2006 | WO2006024547A2 Protease resistant human and non-human hmgb1 box-a mutants and their therapeutic/diagnostic use |
| 03/09/2006 | WO2006024543A1 Vaccine against severe accute respiratory syndrome causing coronavirus (sars-cov) |
| 03/09/2006 | WO2006024533A1 Chemokine binding activity of viral tnf receptors and related proteins |
| 03/09/2006 | WO2006024509A2 Disarmed agrobacterium strains, ri-plasmids, and methods of transformation based thereon |
| 03/09/2006 | WO2006024484A1 Diagnostics and therapeutics for diseases associated with muscarinic acetylcholine receptor 5 (acm5) |
| 03/09/2006 | WO2006024483A1 Diagnostics and therapeutics for diseases associated with muscarinic acetylcholine receptor 3 (acm3) |
| 03/09/2006 | WO2006024351A1 Herbicide-resistant sunflower plants, plynucleotides encoding herbicide-resistant acetohydroxy acid synthase large subunit proteins, and methods of use |
| 03/09/2006 | WO2006015165A9 Optimized interferon-beta gene |
| 03/09/2006 | WO2006005268A3 Pharmaceutical composition containing polypeptide fragments of serralysins |
| 03/09/2006 | WO2006003427A8 A protein involved in carcinoma |
| 03/09/2006 | WO2005123759A8 Fgfr binding peptides |
| 03/09/2006 | WO2005118822A3 Generation of plants with altered oil content |
| 03/09/2006 | WO2005104823A8 Shade responsive promoter, promoter control elements, and combinations and uses thereof |
| 03/09/2006 | WO2005103684A3 Diagnostics and therapeutics for diseases associated with cx3c chemokine receptor 1 (cx3cr1) |
| 03/09/2006 | WO2005102387A3 Therapeutic use of anti-cs1 antibodies |
| 03/09/2006 | WO2005098444A3 Monocarboxylate transporters expressed in cancer cells |
| 03/09/2006 | WO2005082927A3 Antihypertensive peptides |
| 03/09/2006 | WO2005077976A3 Coiled-coil domains from c4b-binding protein |
| 03/09/2006 | WO2005076696A3 Pneumolysin derivatives |
| 03/09/2006 | WO2005072347A3 Inositol 1,4,5- trisphosphate receptor mutants and uses thereof |
| 03/09/2006 | WO2005063820A3 Il-7 fusion proteins |
| 03/09/2006 | WO2005060664A3 Stress tolerant plants and methods thereof |
| 03/09/2006 | WO2005044993A3 Compositions and methods of using apoptosis signaling kinase related kinase (askrk) |
| 03/09/2006 | WO2005025312A3 Insecticidal compounds and methods for selection thereof |
| 03/09/2006 | WO2003066879A3 Amino acid transporters |
| 03/09/2006 | US20060053515 Using transgenic plants as bioreactors for synthesis of hemoglobin |
| 03/09/2006 | US20060053513 Method for producing ketocarotenoids by cultivating genetically modified organisms |
| 03/09/2006 | US20060053505 Bioluminescent novelty items |
| 03/09/2006 | US20060053503 Cranial and vertebral defects associated with loss-of-function of Nell |
| 03/09/2006 | US20060053499 An invertebrate animal model with neurodegenerative phenotype for screening and testing substances |
| 03/09/2006 | US20060053498 Full-length human cdnas encoding potentially secreted proteins |
| 03/09/2006 | US20060053496 Caterpiller gene family |
| 03/09/2006 | US20060052951 Methods and compositions for cancer treatment relating to BRCA1 BRCT domain recognition of phosphorylated BACH1 |
| 03/09/2006 | US20060052593 diagnostics, and vaccines for prophylactic and therapeutic treatment of cancers, particularly ovarian and colon cancers, autoimmune diseases, and related conditions |
| 03/09/2006 | US20060052591 Methods and materials relating to carcinoembryonic antigen-like (cea-like) polypeptides and polynucleotides |
| 03/09/2006 | US20060052586 Process for preparation of mixtures of polypeptides using purified hydrobromic acid |
| 03/09/2006 | US20060052584 Human-derived bradeion proteins, DNA coding for the proteins, and uses thereof |
| 03/09/2006 | US20060052583 Protein production |
| 03/09/2006 | US20060052581 Chimeric proteins for diagnosis and treatment of diabetes |
| 03/09/2006 | US20060052580 Chimeric proteins for diagnosis and treatment of diabetes |
| 03/09/2006 | US20060052421 Conjugation agent |